Clinical Trials in Texas

Showing 1841-1860 of 7,265 trials

An Evaluation of the Safety of CSF-1 in Presbyopic Subjects

NCT05393895

This is a multi-center, double-masked, vehicle-controlled study. The purpose of the study is to evaluate the safety of CSF-1 compared with vehicle in presbyopic subjects. Subjects will be treated for at least 6 weeks.

Presbyopia

Orasis Pharmaceuticals Ltd.178 participantsStarted Apr 2022

Newport Beach, California, United States • Petaluma, California, United States • Colorado Springs, Colorado, United States +9 more locations

Active Not RecruitingPhase 342 miles

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

NCT05599191

This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC).

CoughRefractory Chronic Cough

Bellus Health Inc. - a GSK company825 participantsStarted Oct 2022

Litchfield Park, Arizona, United States • Scottsdale, Arizona, United States • Encinitas, California, United States +188 more locations

An Evaluation of the Safety of CSF-1 in Presbyopic Subjects

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Find Trials by Condition in Texas

A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)

AVID100 in Advanced Epithelial Carcinomas

ProVIDE II Bridging Study

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)

Study of NKTR 255 in Combination With Cetuximab in Solid Tumors

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer

Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors

Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6

D-PLEX 312 - Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II)

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response Study

A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas